Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Attention Disorders|April 11, 2008
Vigilance and sustained attention in children and adults with ADHDLara Tucha, Oliver Tucha, Susanne Walitza, et al.Diabetes Care|August 11, 2016
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized TrialChantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, et al.Psychopharmacology|March 8, 2006
Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorderOliver Tucha, Sylvia Prell, Lara Mecklinger, et al.Alimentary Pharmacology & Therapeutics|June 28, 2019
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesityPhilip Newsome, Sven Francque, Stephen Harrison, et al.Attention Deficit and Hyperactivity Disorders|March 25, 2011
A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeksEberhard Schulz, Christian Fleischhaker, Klaus Hennighausen, et al.Contemporary Clinical Trials|October 11, 2020
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkersStephen A Harrison, Salvatore Calanna, Kenneth Cusi, et al.The New England Journal of Medicine|November 13, 2020
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisPhilip N Newsome, Kristine Buchholtz, Kenneth Cusi, et al.Journal of Child and Adolescent Psychopharmacology|October 27, 2010
A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom settingEberhard Schulz, Christian Fleischhaker, Klaus Hennighausen, et al.Diabetes Care|May 6, 2020
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER TrialJohn B Buse, Stephen C Bain, Johannes F E Mann, et al.Pageof 2